Company Filing History:
1 out of 5 
1 out of 42 
Years Active: 2014
Title: Sylvie Marin: Innovator in Hemophilia Treatment
Introduction
Sylvie Marin is a notable inventor based in Communay, France. She has made significant contributions to the field of medicine, particularly in the treatment of hemophilia A. Her innovative work has led to the development of improved human FVIII variants, which are crucial for patients suffering from this condition.
Latest Patents
Sylvie Marin holds 1 patent for her invention titled "VIII factors for the treatment of type A hemophilia." This patent relates to enhanced human FVIII variants that feature at least one substitution in the A2 and/or C2 domain. The invention is particularly relevant for treating hemophilia A in patients with inhibitors, showcasing her commitment to advancing medical treatments.
Career Highlights
Throughout her career, Sylvie has worked with reputable organizations such as Biomethodes and Hospices Civils De Lyon. Her experience in these institutions has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Didier Saboulard and Jean-Luc Plantier. Their collaborative efforts have further enriched the research and development of treatments for hemophilia.
Conclusion
Sylvie Marin's contributions to the field of hemophilia treatment exemplify her dedication to innovation and improving patient care. Her work continues to inspire advancements in medical science.